BioMerieux Property, Plant, and Equipment 2017-2024 | BMXMF
BioMerieux property, plant, and equipment from 2017 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- BioMerieux property, plant, and equipment for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux property, plant, and equipment for 2023 was $1.469B, a 11.5% increase from 2022.
- BioMerieux property, plant, and equipment for 2022 was $1.317B, a 1.15% increase from 2021.
- BioMerieux property, plant, and equipment for 2021 was $1.302B, a 21.42% increase from 2020.
| BioMerieux Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023 | $1,469 |
| 2022 | $1,317 |
| 2021 | $1,302 |
| 2020 | $1,073 |
| 2019 | $1,002 |
| 2018 | $954 |
| 2017 | $804 |
| 2016 | $813 |
| 2015 | $0 |
| BioMerieux Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.407B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||